Sunday, December 22, 2024

The Future of Advanced Patient Care

Dr. Rod Fontecilla of Guidehouse joins us today to discuss how digital twins can advance patient care via simulation environments and immersive experiences to improve efficiency across clinical facilities, medical centers, and outpatient clinics, as well as advance personalized medicine.

Click here to listen to more episodes of Keeping IT Brief.

About Dr. Rod Fontecilla

Dr. Fontecilla has more than 30 years of experience in implementing large and complex mission-critical IT solutions for both the federal government and commercial sector. He oversees Guidehouse’s strategic research and development efforts, advances initiatives to expand corporate technical competencies and capabilities, and fosters the development of innovative solutions. In doing so, Dr. Fontecilla leads all aspects of technology development in artificial intelligence, machine learning, and predictive analytics, including data analytics, software engineering, application modernization, and cloud computing.

About Guidehouse

Guidehouse is a leading global provider of consulting and outsourcing services to the public sector and commercial markets, with broad capabilities in management, technology, and risk. Recognized as the third-largest healthcare management consulting firm by Modern Healthcare in 2021, the Guidehouse Health team helps hospitals and health systems, government agencies, life sciences and retail companies, employers, and payers solve their most complex issues, overcome unique market challenges, and deliver innovative services to their communities and customers. Visit the Guidehouse Center for Health Insights for health industry research, trends, and best practices.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

FORUM Editor
FORUM Editorhttps://insights.govforum.io
Content Analyst for FORUM and Author on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required